Cargando…

Impaired Kidney Function Associated with Increased Risk of Side Effects in Patients with Small Vessel Vasculitis Treated with Rituximab as an Induction Therapy

Rituximab (RTX), a monoclonal antibody against the CD20 molecule, is used as an induction therapy in the treatment of small vessel vasculitis (SVV). The aim of the study was to evaluate the efficacy and safety of RTX induction therapy for refractory SVV. A retrospective analysis of 20 patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rymarz, Aleksandra, Matyjek, Anna, Sułek-Jakóbczyk, Magdalena, Mosakowska, Magdalena, Niemczyk, Stanisław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920022/ https://www.ncbi.nlm.nih.gov/pubmed/33669267 http://dx.doi.org/10.3390/jcm10040786

Ejemplares similares

The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis
por: Rymarz, Aleksandra, et al.
Publicado: (2021)

Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies
por: Mosakowska, Magdalena, et al.
Publicado: (2021)

Noninfectious, Severe Cryoglobulinemic Vasculitis with Renal Involvement – Safety and Efficacy of Long-Term Treatment with Rituximab
por: Leśniak, Ksymena, et al.
Publicado: (2021)

Protein energy-wasting associated with nephrotic syndrome – the comparison of metabolic pattern in severe nephrosis to different stages of chronic kidney disease
por: Matyjek, Anna, et al.
Publicado: (2020)

Advanced Chronic Kidney Disease is a Strong Predictor of Hypogonadism and is Associated with Decreased Lean Tissue Mass
por: Skiba, Ryszard, et al.
Publicado: (2020)

Serum Osteoprotegerin Is an Independent Marker of Metabolic Complications in Non-DialysisDependent Chronic Kidney Disease Patients
por: Rymarz, Aleksandra, et al.
Publicado: (2021)

The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement
por: Rymarz, Aleksandra, et al.
Publicado: (2018)

Testosterone Replacement Therapy in Chronic Kidney Disease Patients
por: Skiba, Ryszard, et al.
Publicado: (2022)

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome—A Single Center Prospective Study
por: Matyjek, Anna, et al.
Publicado: (2021)

Comparison of Skinfold Thicknesses and Bioimpedance Spectroscopy to Dual-Energy X-Ray Absorptiometry for the Body Fat Measurement in Patients With Chronic Kidney Disease
por: Rymarz, Aleksandra, et al.
Publicado: (2017)

Left Ventricular Diastolic Dysfunction in Chronic Kidney Disease Patients Not Treated with Dialysis
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Relationships between Sclerostin, Leptin and Metabolic Parameters in Non-Dialysis Chronic Kidney Disease Males
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Vascular and Vasogenic Manifestations of Systemic ANCA-Associated Vasculitis with Renal Involvement in Non-Contrast Brain MRI in Patients with Acute Disease Onset
por: Lubas, Arkadiusz, et al.
Publicado: (2022)

Serum Osteoprotegerin Is an Independent Marker of Left Ventricular Hypertrophy, Systolic and Diastolic Dysfunction of the Left Ventricle and the Presence of Pericardial Fluid in Chronic Kidney Disease Patients
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Resistin Contribution to Cardiovascular Risk in Chronic Kidney Disease Male Patients
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Rituximab for the Treatment of Pediatric Double-Positive Small-Vessel Vasculitis
por: Timmermans, Sjoerd A.M.E.G., et al.
Publicado: (2019)

Application of dynamic optimisation for planning a haemodialysis process
por: Stecz, Wojciech, et al.
Publicado: (2019)

Low Free Triiodothyronine as a More Sensitive Predictor of Survival Than Total Testosterone among Dialysis Men
por: Leśniak, Ksymena, et al.
Publicado: (2023)

Peritoneal dialysis in an adult patient with tetralogy of Fallot diagnosed with incomplete Alagille syndrome
por: Ponikowska, Malgorzata, et al.
Publicado: (2020)

Low lean tissue mass can be a predictor of one-year survival in hemodialysis patients
por: Rymarz, Aleksandra, et al.
Publicado: (2018)

Ocular Involvement of Granulomatosis with Polyangiitis
por: Byszewska, Anna, et al.
Publicado: (2023)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
por: Cortazar, Frank B., et al.
Publicado: (2017)

Melatonin Treatment in Kidney Diseases
por: Markowska, Magdalena, et al.
Publicado: (2023)

A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis
por: Awad, Neveen, et al.
Publicado: (2016)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
por: Treppo, Elena, et al.
Publicado: (2021)

Testosterone Deficiency and Nutritional Parameters as Predictors of All-Cause Mortality among Male Dialysis Patients
por: Leśniak, Ksymena, et al.
Publicado: (2022)

Vancomycin dosing in patients undergoing maintenance hemodialysis
por: Rymarz, Aleksandra, et al.
Publicado: (2014)

Nutritional Status, Selected Nutrients Intake and Their Relationship with the Concentration of Ghrelin and Adiponectin in Patients with Diabetic Nephropathy
por: Boniecka, Iwona, et al.
Publicado: (2021)

Mixed Cryoglobulinaemia Vasculitis Treated with Obinutuzumab in a Patient Allergic to Rituximab
por: Gaudêncio, Margarida, et al.
Publicado: (2021)

Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange
por: Sagmeister, Michael S., et al.
Publicado: (2018)

Rituximab-Associated Flare of Cryoglobulinemic Vasculitis
por: Sy-Go, Janina Paula T., et al.
Publicado: (2021)

Induction treatment of previously undiagnosed ANCA-associated vasculitis in a renal transplant patient with Rituximab
por: Graham-Brown, M. P. M., et al.
Publicado: (2016)

Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report
por: Harris, Claire, et al.
Publicado: (2018)

Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Shah, Shivani, et al.
Publicado: (2017)

Small vessel vasculitis
por: Brogan, Paul, et al.
Publicado: (2009)

Large vessel vasculitis
por: Gulati, Ashima, et al.
Publicado: (2009)

Clinical study of renal impairment in patients with propylthiouracil-induced small-vessel vasculitis and patients with primary ANCA-associated small-vessel vasculitis
por: CAO, XIAOZHI, et al.
Publicado: (2013)

Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab
por: Yoshida, Shun, et al.
Publicado: (2020)

Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
por: Aqeel, Faten, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h20lkakiu7vnjhmdpba37muvuj